Enemem, Agreed, no sense dwelling on past mistakes, other than hopefully learning from them. But the stock is still trading, so the Cortex saga isn't quite over. And whoever ends up with the Ampakine compounds might still do something with them.
Lilly and others may have 'wiped out' with their AMPA approaches, but Cortex's compounds have a different mechanism and had clinical successes in ADHD, RD, and SA, so there may still be a future for them eventually -